<DOC>
	<DOCNO>NCT02148614</DOCNO>
	<brief_summary>AIMS Phase 1 . Verify whether intake LibramedR able induce well endocrine metabolic profile . Phase 2 . Verify whether treatment LibramedR 60 day produce good glycaemic profile oral glucose load . SUBJECTS Will recruit 80 obese child phase 1 40 obese child phase 2 . Subjects randomly assign treatment placebo LibramedR double blind clinical trial . METHODS Experimental protocol phase 1 Each child arrive UOC 8 a.m. , fast . A blood sample take . Then patient give two LibramedR tablet placebo . After 20 minute give mixed meal ( equal 15 kcal per kg lean body mass ) . Blood sample take 30-minute interval first two hour 60 minute follow two hour , determination metabolite hormones total 4 hour . The level satiety quantify visual analog scale . Experimental protocol phase 2 Based result OGTT perform recruitment phase , child divide two group : group A , child blood glucose 2 hour oral load high median group B , child blood glucose 2 hour oral load median . The child group A randomly assign LibramedR treatment placebo 60 day , repeat Anthropometric measurement , bioelectrical impedance , OGTT blood chemistry . They also repeat dietary sport anamnesis . During 60 day , child group receive dietary treatment consist low-calorie balanced diet , recommendation practice sport . Every 15 day research assistant contact family reinforce treatment adherence . EXPECTED RESULTS Phase 1 LibramedR intake cause low increase postprandial blood glucose , insulin , triglyceride great decrease ghrelin level compare placebo treatment ; Phase 2 The treatment LibramedR associate decrease blood glucose insulin secretion OGTT compare placebo treatment .</brief_summary>
	<brief_title>Effects Intake Polysaccharides Mix Metabolism , Hormones Satiety Obese Children .</brief_title>
	<detailed_description>INTRODUCTION The postprandial phase fundamental role metabolic regulation . In fact , expose high level substrate glucose fatty acid food intake tends increase risk cardiovascular disease . This even relevant reference amount hour subject postprandial condition therefore expose high concentrated substrate . Food intake , moreover , regulate gastrointestinal secretion hormone help balance hunger satiety , regulate nutrient supply peripheral substrate consumption . An obese subject , due excessive body fat accumulation , present high insulin , glucose triglyceride blood level , blood pressure increase risk cardiovascular disease . Since body time postprandial phase , substrate hormone containment hour food intake help limit exposition cardiovascular risk potential metabolic vascular damage . On equal food energy intake , meal 's composition great influence postprandial hormonal metabolic profile . A high lipid/carbohydrate ratio meal , instance , produce high postprandial triglyceride GLP-1 secretion , low glucose insulin level isocaloric , isoproteic meal low lipid/carbohydrate ratio . The intake polysaccharide macromolecule produce endoluminal gel reduces delay absorption intestinal nutrient , especially glucose lipid . The intake soluble fibre associate well glycaemic profile postprandial lipemia . At present , know whether intake macromolecule Policaptil Gel RetardR polysaccharide ( LibramedR ) meal affect metabolic response ( substrate oxidation , hormonal circulating nutrient variation ) satiate effect compare meal take placebo , could therefore help reduce postprandial cardiovascular risk . AIMS Phase 1 . Verify whether intake LibramedR able induce well endocrine ( low blood insulin ghrelin postprandial level ) metabolic ( decrease postprandial glycaemia , fatty acid triglyceride ) profile . Phase 2 . Verify whether treatment LibramedR 60 day produce good glycaemic profile oral glucose load . SUBJECTS The standard clinical practice UOC Diabetology , Clinical Nutrition Obesity Children Pediatrics , ULSS 20 Verona obese child , consist medical examination assessment stage pubertal development , anthropometric measurement ( height , weight , waist circumference ) , bioimpedance analysis body composition ( TanitaR ) , dietary anamnesis ( food diary ) sport anamnesis ( hour per day video exposure hour per week sport ) . On next day , patient performs oral glucose load curve ( OGTT ) , blood chemistry sample determination lipid profile ALT . These practice , common clinical procedure , part present project . Within group patient clinical biochemical characteristic , recruit study 80 child phase 1 40 child phase 2 . Phase 1 Inclusion criterion : age ( 10 + 2 year ) , ethnicity ( Caucasians ) , obesity ( BMI &gt; cut-off BMI age gender indicative obesity , define International Obesity Task Force ) , acceptance take part study . Exclusion criterion : birth defect , genetic disorder , chronic disease , obesity secondary chronic intake drug endocrine cause genetic therapy obesity already progress . Phase 2 Inclusion criterion : age ( 10 + 2 year ) , ethnicity ( Caucasians ) , obesity , acceptance take part study , blood glucose level 2 hour oral glucose tolerance test ( perform prior recruitment ) median reference . Exclusion criterion : birth defect , genetic disorder , chronic disease , obesity secondary chronic intake drug endocrine cause genetic therapy obesity already progress , blood glucose 2 hour oral glucose load median reference . Subjects randomly assign treatment placebo LibramedR double blind clinical trial . METHODS Experimental protocol phase 1 Each child arrive UOC 8 a.m. , fast since 9 p.m. previous evening . A blood sample take needle cannula antecubital vein . Then patient give two LibramedR tablet placebo . After another 20 minute give mixed meal consume within 20 minute . Blood sample take 30-minute interval first two hour 60 minute follow two hour , determination metabolite hormones total 4 hour ( baseline + 6 blood sample ) . Sample meal The child mixed meal equal 15 kcal per kg lean body mass , order standardize intake accord metabolically active mass . Meal composition : bread , cook ham , ice cream ( stracciatella ) , water , cheese ( PhiladelphiaR ) . % total energy : protein 12.2 % carbohydrate 52.6 % , lipid 35,2 % , fiber 8 % ( caloric density equal 1.4 kcal/g ) . Subjective appetite The level satiety quantify visual analog scale simplify use child 30-minute interval first two hour 60 minute follow two hour . Experimental protocol phase 2 Based result OGTT perform recruitment phase , child divide two group : group A , child blood glucose 2 hour oral load high median ( low glucose tolerance ) group B , child blood glucose 2 hour oral load median ( great glucose tolerance ) . The child low glucose tolerance randomly assign LibramedR treatment placebo 60 day ( two tablet daily ) , repeat Anthropometric measurement , bioelectrical impedance , OGTT blood chemistry ( lipid profile , ALT HbA1c ) . They also repeat dietary sport anamnesis . During 60 day , child group receive dietary treatment consist low-calorie ( less 30 % energy requirement estimate sex , age height ) balance ( protein = 15 % , carbohydrates = 55 % , lipids = 30 % ) diet , recommendation change sedentary lifestyle practice sport . Every 15 day research assistant contact family reinforce treatment adherence . STATISTICAL ANALYSIS Calculating sample size phase 1 The sample size calculate detect difference least 300 mg / dl * 240 min . AUC glucose measure zero 240 minute take test group receive LibramedR meal one take placebo , 85 % power 5 % alpha error . The mean standard deviation glucose AUC group receive placebo obtain previous study carry group ( C Maffeis et al . vs. A High-Fat . Moderate-fat Meal Obese Boys : Nutrient Balance , Appetite , Gastrointestinal Hormone Changes , Obesity 2010 ; 18 ( 3 ) :449-55 ) . The average value group take LibramedR 8 % low placebo group , standard deviation supposedly equal group take placebo . Calculating sample size phase 2 The sample size calculate detect difference 2100 mg / dl * min . glucose AUC measure 0 120 minute oral glucose load group treat LibramedR placebo group , 90 % power 5 % alpha error . The mean standard deviation AUC glucose placebo arm take internal database 100 patient perform glucose tolerance curve arm 's standard deviation LibramedR supposedly equal arm . Statistical analysis phase 1 The mean value physical , biochemical metabolic variable area curve ( AUC ) metabolites hormones child take LibramedR compare Student 's test two-tailed unpaired data child take placebo , non-parametric test , specify . Postprandial metabolic hormonal parameter change two group compare ANOVA repeat measure . The SPSS 21.0 software use perform analysis . The level significance test set p &lt; 0.05 . Statistical analysis phase 2 In group , average physical , biochemical metabolic variable area curve ( AUC ) glucose insulin value recruitment ( baseline ) compare follow-up value , Student 's test pair data , non-parametric test , specify . The comparison delta variable measure baseline follow-up group treat LibramedR placebo group perform Student 's test two queue unpaired data non-parametric test , specify . Hormonal metabolic parameter change afterload glucose two group compare ANOVA repeat measure . The software SPSS 21.0 use perform analysis . The level significance test set p &lt; 0.05 . EXPECTED RESULTS Protocol phase 1 LibramedR intake cause low increase postprandial blood glucose , insulin , triglyceride great decrease ghrelin level compare placebo treatment ; Protocol phase 2 The treatment LibramedR associate decrease blood glucose insulin secretion OGTT compare placebo treatment .</detailed_description>
	<mesh_term>Hormones</mesh_term>
	<criteria>age , ethnicity ( Caucasians ) , obesity ( BMI &gt; cutoff BMI age gender indicative obesity , define International Obesity Task Force ) , acceptance take part study . Exclusion criterion : birth defect , genetic disorder , chronic disease , obesity secondary chronic intake drug endocrine cause genetic therapy obesity already progress .</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>